Cellyan Biotechnology Co., Ltd (HKPD)
Cellyan Biotechnology Co., Ltd at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
Cellyan Biotechnology Co., Ltd (HKPD) is a Medical - Pharmaceuticals company based in HK with a market capitalization of $5.7M. Revenue grew 21.7% year-over-year and the company generated $414.2K in free cash flow. This page tracks HKPD's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
HK · 27 employees · IPO Jan 15, 2025
Valuation
Valuation & price
$0.55 · as of May 26, 2026 · -68.4% vs 52w high
—
P/E ratio
Latest-FY diluted EPS
1.14
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$5.7M
Market cap
21.7%
Revenue growth (YoY)
11.9%
Gross margin
$414.2K
Free cash flow (USD)
-$630.7K
Net debt
Net cash position
22.5%
Share dilution
3/4
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2023 → 2025
Free cash flow by year
2023 → 2025
Gross margin by year
2023 → 2025
Value screen
Graham defensive-investor tests
0
Insider buys · 90 days
0
Insider sells · 90 days
Earnings
Last reported: —
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
Questions
Frequently asked questions
What is Cellyan Biotechnology Co., Ltd's market cap?
Cellyan Biotechnology Co., Ltd (HKPD) has a market capitalization of $5.7M.
What is HKPD's P/E ratio?
A meaningful P/E ratio is not available for HKPD — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.
What is HKPD's price-to-book (P/B) ratio?
HKPD trades at 1.14 times book value per share.
Are insiders buying HKPD stock?
SEC Form 4 filings show no open-market insider buys at Cellyan Biotechnology Co., Ltd in the last 90 days (0 sells).
Same arena
Related companies in Medical - Pharmaceuticals
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.